[HTML][HTML] Impact of doxorubicin-loaded ferritin nanocages (FerOX) vs. free doxorubicin on T lymphocytes: a translational clinical study on breast cancer patients …

M Sevieri, F Andreata, F Mainini, L Signati… - Journal of …, 2024 - Springer
Despite the advent of numerous targeted therapies in clinical practice, anthracyclines,
including doxorubicin (DOX), continue to play a pivotal role in breast cancer (BC) treatment …

[HTML][HTML] Impact of doxorubicin-loaded ferritin nanocages (FerOX) vs. free doxorubicin on T lymphocytes: a translational clinical study on breast cancer patients …

M Sevieri, F Andreata, F Mainini, L Signati… - Journal of …, 2024 - ncbi.nlm.nih.gov
Despite the advent of numerous targeted therapies in clinical practice, anthracyclines,
including doxorubicin (DOX), continue to play a pivotal role in breast cancer (BC) treatment …

[HTML][HTML] Impact of doxorubicin-loaded ferritin nanocages (FerOX) vs. free doxorubicin on T lymphocytes: a translational clinical study on breast cancer patients …

M Sevieri, F Andreata, F Mainini… - Journal of …, 2024 - jnanobiotechnology.biomedcentral …
Despite the advent of numerous targeted therapies in clinical practice, anthracyclines,
including doxorubicin (DOX), continue to play a pivotal role in breast cancer (BC) treatment …

[PDF][PDF] Impact of doxorubicin-loaded ferritin nanocages (FerOX) vs. free doxorubicin on T lymphocytes: a translational clinical study on breast cancer patients …

M Sevieri, F Andreata, F Mainini, L Signati, F Piccotti… - 2024 - boa.unimib.it
Despite the advent of numerous targeted therapies in clinical practice, anthracyclines,
including doxorubicin (DOX), continue to play a pivotal role in breast cancer (BC) treatment …

Impact of doxorubicin-loaded ferritin nanocages (FerOX) vs. free doxorubicin on T lymphocytes: a translational clinical study on breast cancer patients undergoing …

M Sevieri, F Andreata, F Mainini… - Journal of …, 2024 - pubmed.ncbi.nlm.nih.gov
Despite the advent of numerous targeted therapies in clinical practice, anthracyclines,
including doxorubicin (DOX), continue to play a pivotal role in breast cancer (BC) treatment …

Impact of doxorubicin-loaded ferritin nanocages (FerOX) vs. free doxorubicin on T lymphocytes: a translational clinical study on breast cancer patients undergoing …

M Sevieri, F Andreata, F Mainini… - Journal of …, 2024 - search.ebscohost.com
Despite the advent of numerous targeted therapies in clinical practice, anthracyclines,
including doxorubicin (DOX), continue to play a pivotal role in breast cancer (BC) treatment …

Impact of doxorubicin-loaded ferritin nanocages (FerOX) vs. free doxorubicin on T lymphocytes: a translational clinical study on breast cancer patients undergoing …

M Sevieri, F Andreata, F Mainini, L Signati… - JOURNAL OF …, 2024 - re.public.polimi.it
Despite the advent of numerous targeted therapies in clinical practice, anthracyclines,
including doxorubicin (DOX), continue to play a pivotal role in breast cancer (BC) treatment …

Impact of doxorubicin-loaded ferritin nanocages (FerOX) vs. free doxorubicin on T lymphocytes: a translational clinical study on breast cancer patients undergoing …

M Sevieri, F Andreata, F Mainini, L Signati… - Journal of …, 2024 - europepmc.org
Despite the advent of numerous targeted therapies in clinical practice, anthracyclines,
including doxorubicin (DOX), continue to play a pivotal role in breast cancer (BC) treatment …

Impact of doxorubicin-loaded ferritin nanocages (FerOX) vs. free doxorubicin on T lymphocytes: a translational clinical study on breast cancer patients undergoing …

M Sevieri, F Andreata, F Mainini, L Signati… - JOURNAL OF …, 2024 - boa.unimib.it
Despite the advent of numerous targeted therapies in clinical practice, anthracyclines,
including doxorubicin (DOX), continue to play a pivotal role in breast cancer (BC) treatment …

Impact of doxorubicin-loaded ferritin nanocages (FerOX) vs. free doxorubicin on T lymphocytes: a translational clinical study on breast cancer patients undergoing …

M Sevieri, F Andreata, F Mainini, L Signati… - Journal of …, 2024 - europepmc.org
Despite the advent of numerous targeted therapies in clinical practice, anthracyclines,
including doxorubicin (DOX), continue to play a pivotal role in breast cancer (BC) treatment …